Ameriprise’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $20.8M | Buy |
270,262
+359
| +0.1% | +$28K | ﹤0.01% | 1379 |
|
|
2025
Q4 | $21.3M | Sell |
269,903
-21,938
| -8% | -$1.9M | ﹤0.01% | 1372 |
|
|
2025
Q3 | $26.7M | Sell |
291,841
-90,754
| -24% | -$7.4M | 0.01% | 1206 |
|
|
2025
Q2 | $25M | Sell |
382,595
-8,237
| -2% | -$536K | 0.01% | 1219 |
|
|
2025
Q1 | $26.2M | Buy |
390,832
+119,027
| +44% | +$7.11M | 0.01% | 1160 |
|
|
2024
Q4 | $15M | Buy |
271,805
+34,586
| +15% | +$1.99M | ﹤0.01% | 1521 |
|
|
2024
Q3 | $14.2M | Buy |
237,219
+3,865
| +2% | +$236K | ﹤0.01% | 1532 |
|
|
2024
Q2 | $14.9M | Sell |
233,354
-9,920
| -4% | -$644K | ﹤0.01% | 1466 |
|
|
2024
Q1 | $16.8M | Buy |
243,274
+6,880
| +3% | +$415K | ﹤0.01% | 1411 |
|
|
2023
Q4 | $13M | Sell |
236,394
-11,019
| -4% | -$607K | ﹤0.01% | 1576 |
|
|
2023
Q3 | $14.4M | Sell |
247,413
-10,499
| -4% | -$606K | ﹤0.01% | 1442 |
|
|
2023
Q2 | $13.9M | Sell |
257,912
-43,653
| -14% | -$1.93M | ﹤0.01% | 1512 |
|
|
2023
Q1 | $12M | Sell |
301,565
-30
| -0% | -$1.26K | ﹤0.01% | 1618 |
|
|
2022
Q4 | $12.1M | Sell |
301,595
-4,615
| -2% | -$173K | ﹤0.01% | 1583 |
|
|
2022
Q3 | $9.84M | Buy |
306,210
+2,702
| +0.9% | +$92.5K | ﹤0.01% | 1690 |
|
|
2022
Q2 | $9.01M | Sell |
303,508
-9,965
| -3% | -$287K | ﹤0.01% | 1823 |
|
|
2022
Q1 | $8.81M | Buy |
313,473
+30,396
| +11% | +$1.13M | ﹤0.01% | 2015 |
|
|
2021
Q4 | $13M | Buy |
283,077
+9,132
| +3% | +$392K | ﹤0.01% | 1756 |
|
|
2021
Q3 | $8.99M | Sell |
273,945
-1,322
| -0.5% | -$41.1K | ﹤0.01% | 1939 |
|
|
2021
Q2 | $9.65M | Buy |
275,267
+31,934
| +13% | +$1.09M | ﹤0.01% | 1968 |
|
|
2021
Q1 | $8.79M | Buy |
243,333
+9,687
| +4% | +$303K | ﹤0.01% | 1987 |
|
|
2020
Q4 | $6.79M | Buy |
233,646
+24,873
| +12% | +$712K | ﹤0.01% | 2043 |
|
|
2020
Q3 | $5.89M | Buy |
208,773
+155,208
| +290% | +$4.62M | ﹤0.01% | 1960 |
|
|
2020
Q2 | $1.73M | Sell |
53,565
-3,078
| -5% | -$110K | ﹤0.01% | 2681 |
|
|
2020
Q1 | $2.31M | Buy |
56,643
+1,516
| +3% | +$80.6K | ﹤0.01% | 2402 |
|
|
2019
Q4 | $3.4M | Sell |
55,127
-2,331
| -4% | -$154K | ﹤0.01% | 2461 |
|
|
2019
Q3 | $4.19M | Sell |
57,458
-54,803
| -49% | -$4.1M | ﹤0.01% | 2305 |
|
|
2019
Q2 | $9.23M | Sell |
112,261
-5,130
| -4% | -$365K | ﹤0.01% | 1801 |
|
|
2019
Q1 | $8.28M | Sell |
117,391
-17,172
| -13% | -$1.01M | ﹤0.01% | 1862 |
|
|
2018
Q4 | $6.06M | Sell |
134,563
-6,095
| -4% | -$319K | ﹤0.01% | 1993 |
|
|
2018
Q3 | $7.95M | Buy |
140,658
+57,533
| +69% | +$3.52M | ﹤0.01% | 2042 |
|
|
2018
Q2 | $5.55M | Buy |
83,125
+28,896
| +53% | +$1.8M | ﹤0.01% | 2177 |
|
|
2018
Q1 | $3.16M | Buy |
54,229
+1,184
| +2% | +$75.2K | ﹤0.01% | 2474 |
|
|
2017
Q4 | $3.42M | Sell |
53,045
-715
| -1% | -$44.5K | ﹤0.01% | 2373 |
|
|
2017
Q3 | $2.82M | Sell |
53,760
-445
| -0.8% | -$21.2K | ﹤0.01% | 2435 |
|
|
2017
Q2 | $2.54M | Buy |
54,205
+340
| +0.6% | +$16.4K | ﹤0.01% | 2492 |
|
|
2017
Q1 | $2.67M | Buy |
53,865
+1,000
| +2% | +$56.1K | ﹤0.01% | 2444 |
|
|
2016
Q4 | $3.2M | Buy |
52,865
+1,153
| +2% | +$70.5K | ﹤0.01% | 2383 |
|
|
2016
Q3 | $3.43M | Buy |
51,712
+2,827
| +6% | +$177K | ﹤0.01% | 2260 |
|
|
2016
Q2 | $2.73M | Buy |
48,885
+5,925
| +14% | +$288K | ﹤0.01% | 2364 |
|
|
2016
Q1 | $1.45M | Buy |
42,960
+1,880
| +5% | +$63.8K | ﹤0.01% | 2686 |
|
|
2015
Q4 | $1.85M | Sell |
41,080
-23,030
| -36% | -$991K | ﹤0.01% | 2643 |
|
|
2015
Q3 | $2.53M | Sell |
64,110
-2,527
| -4% | -$144K | ﹤0.01% | 2483 |
|
|
2015
Q2 | $4.13M | Buy |
66,637
+3,277
| +5% | +$195K | ﹤0.01% | 2273 |
|
|
2015
Q1 | $3.96M | Buy |
63,360
+9,895
| +19% | +$602K | ﹤0.01% | 2228 |
|
|
2014
Q4 | $3.02M | Buy |
53,465
+28,860
| +117% | +$1.27M | ﹤0.01% | 2355 |
|
|
2014
Q3 | $696K | Buy |
24,605
+12,655
| +106% | +$379K | ﹤0.01% | 2931 |
|
|
2014
Q2 | $412K | Buy |
+11,950
| New | +$375K | ﹤0.01% | 3062 |
|
Other funds holding ANIP
VCM
SCM
TCM
GAM
DTC
